Acute Kidney Injury During Therapy With an Antisense Oligonucleotide Directed Against PCSK9-Reference-Cited by-同舟云学术

Acute Kidney Injury During Therapy With an Antisense Oligonucleotide Directed Against PCSK9

Published:2013-10 Issue:4 Volume:62 Page:796-800
ISSN:0272-6386
Container-title:American Journal of Kidney Diseases
language:en
Short-container-title:American Journal of Kidney Diseases

Author:

van Poelgeest Eveline P.,Swart Reinout M.,Betjes Michiel G.H.,Moerland Matthijs,Weening Jan J.,Tessier Yann,Hodges Michael R.,Levin Arthur A.,Burggraaf Jacobus

Publisher

Elsevier BV

Subject

Nephrology

Reference37 articles.

1. RNA targeting therapeutics: molecular mechanisms of antisense oligonucleotides as a therapeutic platform;Bennett;Annu Rev Pharmacol Toxicol,2010

2. Antisense therapy in the treatment of hypercholesterolemia;Lippi;Eur J Intern Med,2011

3. Antisense, RNAi, and gene silencing strategies for therapy: mission possible or impossible?;Rayburn;Drug Discov Today,2008

4. Sequence variations in PCSK9, low LDL, and protection against coronary heart disease;Cohen;N Engl J Med,2006

5. Function and distribution of circulating human PCSK9 expressed extrahepatically in transgenic mice;Luo;J Lipid Res,2009

Cited by 79 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Novel and Emerging LDL-C Lowering Strategies: A New Era of Dyslipidemia Management;Journal of Clinical Medicine;2024-02-22

2. Targeted ASO-mediated Atp1a2 knockdown in astrocytes reduces SOD1 aggregation and accelerates disease onset in mutant SOD1 mice;PLOS ONE;2023-11-28

3. Lipid-Lowering Drugs and Risk of Rapid Renal Function Decline: A Mendelian Randomization Study;2023-10-23

4. Focal Segmental Glomerulosclerosis Complicating Therapy With Inotersen, an Antisense Oligonucleotide Inhibitor: A Case Report;American Journal of Kidney Diseases;2023-05

5. ENDOVASCULAR TREATMENT BEFORE OPERATIONS IN CLINIC OF TRAUMATOLOGY AND ORTHOPAEDICS;Vrach;2023-03-03